Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMYMP) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for Bristol Myers Squibb (BMYMP) over the last 10 years, with Q4 2025 value amounting to $5.7 billion.

  • Bristol Myers Squibb's Long-Term Debt Issuances changed N/A to $5.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.7 billion, marking a year-over-year decrease of 5544.52%. This contributed to the annual value of $5.7 billion for FY2025, which is 5544.52% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Long-Term Debt Issuances of $5.7 billion as of Q4 2025.
  • Bristol Myers Squibb's 5-year Long-Term Debt Issuances high stood at $12.9 billion for Q1 2024, and its period low was $4.5 billion during Q4 2023.
  • Over the past 4 years, Bristol Myers Squibb's median Long-Term Debt Issuances value was $5.8 billion (recorded in 2022), while the average stood at $7.3 billion.